Krystal Biotech
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on $10,932,000 and profit margin reached 22%. Total operating expenses were $157,332,000.
Profit Margin
| 2016 | 0 | -1.15M | |
|---|---|---|---|
| 2017 | 0 | -7.92M | |
| 2018 | 1.02M | -10.88M | -1060.27% |
| 2019 | 0 | -19.08M | |
| 2020 | 0 | -32.16M | |
| 2021 | 0 | -69.57M | |
| 2022 | 0 | -139.97M | |
| 2023 | 50.69M | 10.93M | 21.56% |
KRYS Income Statement (2016 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||
Revenue | 50.69M | 0 | 0 | 0 | 0 | 1.02M | 0 | 0 |
Cost of revenue | 3.09M | 4.05M | 2.76M | 1.85M | 974K | 0 | 23K | 0 |
Gross profit | 47.60M | -4.05M | -2.76M | -1.85M | -974K | 1.02M | -23K | 0 |
Operating exp. | ||||||||
Research and development | 46.43M | 42.46M | 27.88M | 17.93M | 15.61M | 7.76M | 3.20M | 741K |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 157.33M | 120.19M | 68.27M | 32.99M | 22.08M | 11.91M | 4.77M | 1.14M |
Operating income | -109.72M | -145.19M | -68.27M | -32.99M | -22.08M | -11.91M | -4.77M | -1.14M |
Other income (expenses), net | 122.62M | 5.22M | -1.29M | 832K | 2.99M | 1.02M | -3.14M | -7K |
Income before tax | 12.89M | -139.97M | -69.57M | -32.16M | -19.08M | -10.88M | -7.92M | -1.15M |
Income tax expense | 1.96M | 0 | 0 | 1.64M | 0 | 0 | 0 | 0 |
Net income | 10.93M | -139.97M | -69.57M | -32.16M | -19.08M | -10.88M | -7.92M | -1.15M |
Earnings per share | ||||||||
Basic EPS | 0.4 | -5.49 | -3.13 | -1.71 | -1.2 | -0.97 | -1.48 | -0.27 |
Diluted EPS | 0.39 | -5.49 | -3.13 | -1.71 | -1.2 | -0.97 | -1.48 | -0.27 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source |